Compass Financial Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49.2K Buy
+305
New +$50.8K 0.01% 747

Other funds holding AZN

Compass Financial Management's AZN Position: Q3 2026 in Review

Compass Financial Management opened a new position in AstraZeneca (AZN) in Q3 2026: 305 shares worth $49.2K. The stake represents 0.01% of the portfolio and ranks #747 among its holdings.

1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Compass Financial Management held 305 shares of AstraZeneca worth $49.2K as of Q3 2026.
  • AstraZeneca was a new Compass Financial Management position in Q3 2026.
  • AstraZeneca made up 0.01% of Compass Financial Management's portfolio in Q3 2026, its #747 holding.
  • 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.